Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16684
Country/Region: Kenya
Year: 2016
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,129,322 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $70,729
Care: TB/HIV (HVTB) $22,269
Care: Pediatric Care and Support (PDCS) $13,207
Health Systems Strengthening (OHSS) $190,000
Testing: HIV Testing and Counseling (HVCT) $63,862
Sexual Prevention: Other Sexual Prevention (HVOP) $525,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $57,974
Treatment: Adult Treatment (HTXS) $166,471
Treatment: Pediatric Treatment (PDTX) $19,810
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 21
HTS_TST Age/sex: 1-9 2017 565
HTS_TST Age/sex: 10-14 Female 2017 175
HTS_TST Age/sex: 10-14 Male 2017 158
HTS_TST Age/sex: 15-19 Female 2017 2,147
HTS_TST Age/sex: 15-19 Male 2017 1,570
HTS_TST Age/sex: 20-24 Female 2017 5,203
HTS_TST Age/sex: 20-24 Male 2017 3,846
HTS_TST Age/sex: 25-49 Female 2017 10,791
HTS_TST Age/sex: 25-49 Male 2017 7,843
HTS_TST Age/sex: 50+ Female 2017 1,072
HTS_TST Age/sex: 50+ Male 2017 838
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,125
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 918
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 41,167
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 34,836
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 78,046
HTS_TST Service Delivery Point (Facility): Index testing 2017 706
HTS_TST Service Delivery Point (Facility): Outpatient 2017 52,676
HTS_TST Service Delivery Point (Facility): PMTCT 2017 3,095
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 111
HTS_TST Service Delivery Point (Facility): VCT 2017 21,458
HTS_TST Sum of Age/Sex disaggregates 2017 33,643
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,043
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 76,003
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 78,046
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 17
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 9
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 78
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 40
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 175
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 105
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 384
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 224
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 34
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 23
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 32
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 67
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 41
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,116
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 596
PMTCT_ART Already on ART at beginning of current pregnancy 2017 203
PMTCT_ART New on ART 2017 77
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 14,433
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 145
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 83
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 4
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 228
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 19
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 100
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 647
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 1,379
PMTCT_STAT By: Known positives at entry 2017 65
PMTCT_STAT By: Number of new positives identified 2017 179
PMTCT_STAT Number of new ANC and L&D clients 2017 14,433
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 14,433
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 12
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 48
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 4
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 8
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 14
PMTCT_STAT Sum of Positives Status disaggregates 2017 244
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 19
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 100
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 647
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 1,379
PP_PREV Aggregated Age/sex: <15 Female 2017 2,959
PP_PREV Aggregated Age/sex: <15 Male 2017 2,428
PP_PREV Aggregated Age/sex: 15+ Female 2017 41,574
PP_PREV Aggregated Age/sex: 15+ Male 2017 43,039
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 90,000
PP_PREV Total number of people in the target population 2017 90,000
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 45
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 68
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 114
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 114
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 489
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 489
TB_SCREENDX Screen Result: Screened Positive for TB 2017 542
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 1,841
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 710
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 81
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 77
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 2,709
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 21
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 636
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 45
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 753
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,455
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,455
TX_CURR Age/Sex: <1 2017 11
TX_CURR Age/Sex: <1-9 2017 102
TX_CURR Age/Sex: 10-14 Female 2017 22
TX_CURR Age/Sex: 10-14 Male 2017 23
TX_CURR Age/Sex: 15-19 Female 2017 38
TX_CURR Age/Sex: 15-19 Male 2017 11
TX_CURR Age/Sex: 20-24 Female 2017 164
TX_CURR Age/Sex: 20-24 Male 2017 35
TX_CURR Age/Sex: 25-49 Female 2017 1,369
TX_CURR Age/Sex: 25-49 Male 2017 494
TX_CURR Age/Sex: 50+ Female 2017 270
TX_CURR Age/Sex: 50+ Male 2017 170
TX_CURR Aggregated Age/Sex: <15 Female 2017 81
TX_CURR Aggregated Age/Sex: <15 Male 2017 77
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,841
TX_CURR Aggregated Age/Sex: 15+ Male 2017 710
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,709
TX_CURR Sum of age/sex disaggregates 2017 49
TX_CURR Sum of Aggregated Age/Sex <15 2017 158
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 2,551
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,709
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 38
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 49
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,038
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 480
TX_NEW By Age/Sex: <1 2017 21
TX_NEW By Age/Sex: 1-9 2017 45
TX_NEW By Age/Sex: 10-14 Female 2017 11
TX_NEW By Age/Sex: 10-14 Male 2017 10
TX_NEW By Age/Sex: 15-19 Female 2017 7
TX_NEW By Age/Sex: 15-19 Male 2017 2
TX_NEW By Age/Sex: 20-24 Female 2017 138
TX_NEW By Age/Sex: 20-24 Male 2017 34
TX_NEW By Age/Sex: 25-49 Female 2017 750
TX_NEW By Age/Sex: 25-49 Male 2017 348
TX_NEW By Age/Sex: 50+ Female 2017 143
TX_NEW By Age/Sex: 50+ Male 2017 96
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,605
TX_NEW Sum of Age/Sex disaggregates 2017 1,539
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,605
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 2,455
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,455
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 78
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 75
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,662
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 640
TX_PVLS Numerator: Indication: Routine 2017 2,455
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 78
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 75
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,662
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 640
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 19
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 45
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 121
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 31
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 668
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 313
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 128
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 88
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 37
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 48
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 922
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 434
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,441
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,605
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 21
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 45
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 138
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 34
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 750
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 347
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 143
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 96
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 38
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 49
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,038
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 480
Cross Cutting Budget Categories and Known Amounts Total: $405,000
Human Resources for Health $270,000
Gender: Gender Based Violence (GBV) $33,750
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Condoms: Policy, Tools, and Services $67,500
Gender: Gender Equality $33,750
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Increase gender-equitable access to income and productive resources, including education
Equity in HIV prevention, care, treatment and support